|
| |
SolvaySolvay has not stopped expanding since it was founded in 1863. The time-line below gives an overview, in key stages, of its development from the beginning until today.Solvay Group began on 15 April 1861, when Ernest Solvay (1838-1922) patented the industrial production of sodium carbonate - also known as soda ash - using common salt, ammonia, carbon dioxide (CO2) and lime.The first Solvay soda factory was opened in Couillet, Belgium in 1865. It used salt from rock salt mines; the lime and CO2 were produced by the calcination of limestone in limekilns. The ammonia was recovered from the production process for re-use.Scientific, technical and commercial competencesIn chemistry and human healthSupplying innovative products and servicesCreating constantly growing added value.
| Contact Details: |
| rue du Prince Albert 33 |
| Brussels |
| |
| B-1050 |
| Belgium |
| Tel: | 32 2 509 69 37 |
| Fax: | 32 2 509 72 40 |
| Email: | webmaster@solvay.com |
| WWW: | www.solvay.com/
|
| |
Recent Publications by Solvay: |  |
Cardio-Renal Effects of the A1 Adenosine Receptor Antagonist SLV320 in Patients With Heart Failure.
BACKGROUND: Blocking the tubuloglomerular feedback mechanism with... | 19th November, 2009
| Kerckhoff-Klinik, Department of Cardiology and Cardiosurgery, Bad Nauheim,
| Circ Heart Fail. 2009 Nov 1;2(6):523-531. Epub 2009 Sep 24.
DOI Direct Link |
Antipsychotic Medication: The Potential Role of 5-HT(1A) Receptor Agonism.
Schizophrenia is a complex psychiatric disorder characterised by positive... | 17th November, 2009
| Solvay Pharmaceuticals Research Laboratories, van Houtenlaan 36, 1381 CP,
| Curr Pharm Des. 2009 Nov 12.
|
2-Methyl-6-(phenylethynyl)-pyridine (MPEP) potentiates ketamine and heroin reward as assessed by acquisition, extinction, and reinstatement of conditioned place preference in the rat.
The mGlu(5) receptor antagonist 2-methyl-6-(phenylethynyl)pyridine (MPEP)... | 2nd September, 2009
| Solvay Pharmaceuticals, Clinical Candidate Selection, Weesp, The
| Eur J Pharmacol. 2009 Mar 15;606(1-3):94-101. Epub 2009 Jan 10.
DOI Direct Link |
Synthesis and SAR of 1,4,5,6-tetrahydropyridazines as potent cannabinoid CB1 receptor antagonists.
The synthesis and structure-activity relationship studies of... | 25th August, 2009
| Solvay Pharmaceuticals, Chemical Design and Synthesis Unit, Research
| Bioorg Med Chem Lett. 2009 Oct 1;19(19):5675-8. Epub 2009 Aug 7.
DOI Direct Link |
The mGlu5 receptor antagonist 2-methyl-6-(phenylethynyl)pyridine (MPEP) supports intravenous self-administration and induces conditioned place preference in the rat.
We recently reported that the mGlu5 receptor antagonist... | 8th July, 2009
| Solvay Pharmaceuticals, Clinical Candidate Selection, CJ van Houtenlaan
| Eur J Pharmacol. 2009 Apr 1;607(1-3):114-20.
|
→View more Solvay research publications. |
Press Releases on Solvay:
|
 |
| Reportlinker Adds World Bioplastics Industry |
10th November, 2009 |
Reportlinker |
NEW YORK, Nov. 10 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue.
World Bioplastics Industry
http://www.reportlinker.com/p0158674/World
|
| Watson Reports Third Quarter 2009 GAAP EPS of $0.55; Adjusted EPS of $0.66 |
4th November, 2009 |
Watson Pharmaceuticals, Inc. |
Third Quarter 2009 Business Segment Results
September 30, September 30,
------------- --------------
|
| Reportlinker Adds Opportunity Analysis of H1N1 (swine flu) Vaccination Market |
3rd November, 2009 |
Reportlinker |
NEW YORK, Nov. 3 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue.
Opportunity Analysis of H1N1 (swine flu) Vaccination Market
http://www
|
| Videos: Solvay Pharmaceuticals, Inc. Announces Thriving Student Achiever and Awards $17K SolvayCARES(SM) Scholarship to College Student with Cystic Fibrosis |
29th October, 2009 |
Solvay Pharmaceuticals, Inc. |
MARIETTA, Ga., Oct. 29 /PRNewswire/ -- Solvay Pharmaceuticals, Inc. today announced that Amanda Rudd has been awarded the title of 2009 Thriving Student Achiever for her creative entry expressing her
|
| CREON(R) (pancrelipase) Delayed-Release Capsules Improves Digestive Outcomes In Adults With Chronic Pancreatitis |
26th October, 2009 |
Solvay Pharmaceuticals, Inc. |
MARIETTA, Ga., Oct. 26 /PRNewswire/ -- Solvay Pharmaceuticals, Inc. announced today that new data demonstrate that CREON®( )(pancrelipase) Delayed-Release Capsules significantly improves a key
|
BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 59 individuals from Solvay using this service.  Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 309 times since April 2007, the link to the organisation's website has been followed 42 times Search for more companies in Brussels Search for more companies in This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for Solvay |
